COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Catalog Number EVR35-06-150-120 |
Device Problems
Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
|
Patient Problem
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 05/09/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that an attempt was made to use a everflex entrust to treat a calcified lesion in the right distal superficial femoral artery. degree of tortuosity was little.Degree of calcification was moderate.Lesion stenosis was 80%. a 6f non-medtronic sheath was used.A non-medtronic.035 guidewire was used.Embolic protection was not used.Device was prepped per ifu.The lesion was pre-dilated with a 4mm device.The device did not pass through a previously-deployed stent.Resistance was encountered when advancing the device.Excessive force was not used.Thumbscrew/lock-pin was not checked for securement prior to procedure.Lock pin was removed just prior to attempted deployment.It was reported that stent deformation occurred in vivo during positioning/deployment and there was partial deployment in an inaccurate location. there was no damage to the deployment mechanisms or device handle noted prior to deployment issue.Break/fracture occurred at catheter when trying to un-sheath.The catheter /delivery system was deformed, kinked and stretched.No embolization of any components, all removed.No detached portion of device remains in patient, removed with wire after failed deployment.The procedure was completed with cut down to puncture site and a larger sheath inserted.Pressure placed at undeployed stent.Slow removal to try to un-sheath.
|
|
Manufacturer Narrative
|
Image analysis the images provided confirm that a stent was implanted in the distal superficial femoral artery, it is inconclusive if the stent deformed due to the calcification of the lesion or the partial deployment.Product analysis the strain relief was not returned with the device.The stent was not returned.The handle was returned in two parts, the isolation sheath was in three parts and was separate to the disassembled handle and the deployment wheel and pull wire were detached from the silver retractable isolation sheath no functional testing could be carried out due to the condition of the returned device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|